Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors using a platform of primary human cell based disease models, BioMAP® systems
Sunday lipsinki
Sunday (2) lipinski
Institute of Molecular Virology Westfälische-Wilhelms-University Münster Pursuing New Avenues in Anti-Influenza Therapy Stephan Ludwig Options for the.
Herceptin as a Phase 0 Imaging Example. Phase 0 Trials in Oncology Drug Development Steven M. Larson, M.D. Nuclear Medicine Svc, Department of Radiology.
Editorial Process
Systems medicine and metabolic profiling of diseases
Can a combination of constrained-based and kinetic modeling bridge time scales in progressive diseases?
Univ of Miami CTSI: Citizen science seminar; Oct 2014
Confident Phosphopeptide Identification and Phosphosite Localization by LC-MS/MS - Karl R. Clauser
BioSharing update and next steps - ELIXIR ALL Hands - March, 2015
Humetics 2014 12-10-final
